Lacktman Comments on the FDA’s CDS Draft Guidance

06 February 2018 MobiHealthNews News
Partner Nate Lacktman was quoted in a MobiHealthNews article, “Clinical Decision Support Coalition Letter Criticizes FDA’s Stance on CDS,” as one of the supporters of the FDA’s recent Clinical Decision Support draft guidance. This guidance outlines forms of CDS which won’t be regulated based on the degree of human involvement instead of based on risk.

Lacktman said, “Digital health companies and telemedicine providers should take a moment today and tweet a big thank you to Commissioner Scott Gottlieb (@SGottliebFDA) and the FDA for this long-awaited guidance. Not only has the FDA made great leaps to educate digital health software developers, Commissioner Gottlieb's direction clearly recognizes the need not to over-regulate our industry and instead maintain the delicate balance between protecting patient safety and promoting health innovation.”

Related Services

Insights

European Data Protection Board Issues Recommendations for Exports of Personal Data From the European Economic Area
01 December 2020
Privacy, Cybersecurity & Technology Law Perspectives
Podcast Episode 24: Steve Cade, Partner
01 December 2020
Foley Career Perspectives
U.S. Companies Must Prepare to Pay Higher Wages for Specialty Occupation Foreign Workers
30 November 2020
Labor & Employment Law Perspectives
A Shield for Employers: State COVID-19 Indemnity Laws
30 November 2020
Coronavirus Resource Center:Back to Business
HCCA San Francisco Regional Conference
04 December 2020
Virtual Conference
Webinar: Massachusetts Paid Family and Medical Leave 2021
02 December 2020
Webinar
CTeL Digital Health Summit 2020
01-04 December 2020
Virtual Conference
Virtual CLE Week
Every Tuesday & Thursday from December 1 - 17 2020
Webinar